TNF Pharmaceuticals, Inc. (TNFA)
USD 0.28
(7.26%)
USD 0.28
(7.26%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | 1.66 Million |
| Cost of Revenue | - | - | - | 29.45 Thousand | 74.06 Thousand | 1.7 Million |
| Gross Profit | - | - | - | -29.45 Thousand | -74.06 Thousand | -43.82 Thousand |
| Operating Expenses | 16.36 Million | 15.28 Million | 28.2 Million | 12.25 Million | 3.32 Million | 8.51 Million |
| Selling, General and Administrative Expenses | 8.49 Million | 6.21 Million | 21.45 Million | 4.29 Million | 3.32 Million | 7.44 Million |
| Research and Development Expenses | 7.86 Million | 9.06 Million | 6.74 Million | 7.96 Million | 3.62 Million | 1.06 Million |
| Other Expenses | 762.83 Thousand | - | - | - | - | - |
| Cost and Expenses | 17.12 Million | 15.28 Million | 28.2 Million | 12.28 Million | 3.39 Million | 10.22 Million |
| Operating Income | -17.12 Million | -15.28 Million | -28.2 Million | -12.28 Million | -3.39 Million | -8.55 Million |
| Interest Expense | - | - | 608.46 Thousand | 1.19 Million | - | - |
| Income Tax Expense | - | -15.28 Million | -18.33 Thousand | 5.42 Million | 506.95 Thousand | 5.00 |
| Earnings before Tax | -3.99 Million | -15.19 Million | -29.88 Million | -12.15 Million | -3.38 Million | -10.84 Million |
| Net Income | -3.99 Million | -15.19 Million | -29.88 Million | -17.58 Million | -3.88 Million | -10.84 Million |
| Earnings Per Share Basic | -5.33 | -11.74 | -25.61 | -149.57 | -380.79 | -1423.62 |
| Earnings Per Share Diluted | -5.33 | -11.74 | -25.61 | -149.57 | -380.79 | -1423.62 |
| Weighted Average Shares Outstanding | 1.54 Million | 1.29 Million | 1.16 Million | 117.54 Thousand | 10.21 Thousand | 7620.72 |
| Weighted Average Shares Outstanding (Diluted) | 1.54 Million | 1.29 Million | 1.16 Million | 117.54 Thousand | 10.21 Thousand | 7620.72 |
| Gross Margin | - | - | - | - | - | -0.03 |
| EBIT Margin | - | - | - | - | - | -5.00 |
| Profit Margin | - | - | - | - | - | -6.51 |
| EBITDA | -3.99 Million | - | -29.28 Million | -12.12 Million | -3.3 Million | -10.61 Million |
| Earnings Before Tax Margin | - | - | - | - | - | -5.14 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
| Operating Expenses | 1.86 Million | 2.78 Million | 17.12 Million | 4.9 Million | 3.84 Million | 5.78 Million |
| Selling, General and Administrative Expenses | 1.45 Million | 1.58 Million | - | 1.94 Million | 1.93 Million | 3.55 Million |
| Research and Development Expenses | 401.1 Thousand | 1.19 Million | - | 2.96 Million | 1.91 Million | 2.22 Million |
| Other Expenses | -10.35 Million | - | -762.83 Thousand | - | - | - |
| Cost and Expenses | 1.86 Million | 2.78 Million | 17.12 Million | 4.9 Million | 3.84 Million | 5.78 Million |
| Operating Income | -1.86 Million | -2.78 Million | -17.12 Million | -4.9 Million | -3.84 Million | -5.78 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | -1.86 Million | -2.78 Million | -16.36 Million | -4.9 Million | -3.84 Million | -5.78 Million |
| Earnings before Tax | -9.56 Million | -9.8 Million | -3.99 Million | -2.36 Million | 4.04 Million | -4.16 Million |
| Net Income | -9.56 Million | -9.8 Million | -3.99 Million | -2.36 Million | 4.04 Million | -4.16 Million |
| Earnings Per Share Basic | -4.20 | -4.58 | - | -1.42 | 2.70 | -3.10 |
| Earnings Per Share Diluted | -4.20 | -4.58 | - | -1.42 | 2.70 | -3.10 |
| Weighted Average Shares Outstanding | 2.27 Million | 2.14 Million | 1.54 Million | 1.66 Million | 1.49 Million | 1.34 Million |
| Weighted Average Shares Outstanding (Diluted) | 2.27 Million | 2.14 Million | 1.54 Million | 1.66 Million | 1.49 Million | 1.34 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -1.86 Million | -2.78 Million | - | -4.9 Million | -3.84 Million | -5.78 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
LNR
474490
BVA
OGE
ASAI
0419